Journal Guide

Pathology & Oncology Research (POR) is an interdisciplinary journal at the interface of pathology and oncology, including the preclinical and translational research, diagnostics and therapy. Furthermore, POR offers an international forum for the rapid communication of reviews, original research, critical and topical reports with excellence and novelty. Published quarterly, POR is dedicated to keeping scientists informed of developments in its focused biomedical fields which span the gap between basic research and clinical medicine. A special aim of POR is to promote publishing activity in pathology and oncology of colleagues in the Central and East European region. The journal will interest pathologists, and a broad range of experimental and clinical oncologists, and related experts. Pathology & Oncology Research is supported by distinguished international advisory board and the Arányi Foundation for modern pathology.

Pediatric Blood & Cancer will publish in print and online, the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood, including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.

Pediatric Hematology and Oncology covers all aspects of research and patient management within the area of blood disorders and malignant diseases of childhood. Of interest are clinical studies as well as basic and translational research reports regarding cancer pathogenesis, genetics, molecular diagnostics, pharmacology, stem cells, molecular targeting, cellular and immune therapies. Papers with a focus on supportive care, late effects and on related ethical, legal, psychological, social, cultural, or historical aspects of these fields are also appreciated. Reviews on important developments in the field are welcome. Articles from all over the world are considered for publication. The journal is not dependent on or connected with any organization or society. Read More: http://informahealthcare.com/page/pho/Description.

Official Journal of the European Platform for Photodynamic Medicine Affiliated with the International Photodynamic AssociationAlso affiliated with the British Medical Laser Associationand the Polish Society for Photodynamic MedicineFIRST IMPACT FACTOR (2010): 2.302NOW INDEXED in SciSearch/Science Citation Index Expanded, Current Contents/Clinical Medicine.NOW INCLUDED in MEDLINE/PubMed.Aims and Scope:Photodiagnosis and Photodynamic Therapy is an international journal for the dissemination of scientific knowledge and clinical developments of Photodiagnosis and Photodynamic Therapy in all medical specialties. The journal publishes original articles, review articles, case presentations, "how-to-do-it" articles, Letters to the Editor, short communications and relevant images with short descriptions. All submitted material is subject to a strict peer-review process.Electronic usage:An increasing number of readers access the journal online via ScienceDirect, one of the world's most advanced web delivery systems for scientific, technical and medical information.Average monthly article downloads for this journal: 3,962** Figure is a monthly average of full-text articles downloaded from ScienceDirect between October 2012 and October 2013

Pigment Cell & Melanoma Research publishes manuscripts on all aspects of pigment cells including development, cell and molecular biology, genetics, diseases of pigment cells including melanoma. Papers that provide insights into the causes and progression of melanoma including the process of metastasis and invasion, proliferation, senescence, apoptosis or gene regulation are especially welcome, as are papers that use the melanocyte system to answer questions of general biological relevance. Papers that are purely descriptive or make only minor advances to our knowledge of pigment cells or melanoma in particular are not suitable for this journal.

The overarching mission of PRACTICAL RADIATION ONCOLOGY is to improve the quality of radiation oncology practice. The Journal's purpose is to document the state of current practice, providing background for those in training and continuing education for practitioners, through discussion and illustration of new techniques, evaluation of current practices, and publication of case reports. PRO will strive to provide its readers content that emphasizes knowledge "with a purpose."The content of PRO includes:Articles that focus on imaging, contouring, target delineation, simulation, treatment planning, immobilization, organ motion, and other practical issuesASTRO guidelines, position papers, and consensus statements Invited commentaries"Quality Corner" section focusing on patient safety, quality measurement, or quality improvement initiativesArticles on the maintenance of certification process and practice quality improvement initiatives such as ASTRO's PAAROT program "Point/Counterpoint" section with opposing expert views on current topics and controversiesArticles devoted to professionalism, biomedical ethics, and practice managementClinically oriented reviews of cancer biologyInteresting case reports with pedagogical meritPRO is the sister publication to the International Journal of Radiation Oncology • Biology • Physics. Click here to see which types of papers these journals typically accept.

The Prostate is a peer-reviewed journal dedicated to original studies of this organ and the male accessory glands. It serves as an international medium for these studies, presenting comprehensive coverage of clinical, anatomic, embryologic, physiologic, endocrinologic, and biochemical studies.

Prostate Cancer is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies related to all aspects of prostate cancer.

Prostate Cancer and Prostatic Diseases covers all aspects of prostatic diseases, in particular prostate cancer, the subject of intensive basic and clinical research world-wide. The journal also reports on exciting new developments being made in diagnosis, surgery, radiotherapy, drug discovery and medical management.Prostate Cancer and Prostatic Diseases is of interest to surgeons, oncologists and clinicians treating patients and to those involved in research into diseases of the prostate. The journal covers the three main areas - prostate cancer, BPH and prostatitis.Prostate Cancer and Prostatic Diseases publishes original research articles, reviews, topical comment and critical appraisals of scientific meetings and the latest books. The journal also contains a calendar of forthcoming scientific meetings. The Editors and a distinguished Editorial Board ensure that submitted articles receive fast and efficient attention and are refereed to the highest possible scientific standard. A fast track system is available for topical articles of particular significance.The following is a non-exhaustive list of the general topics covered by Prostate Cancer and Prostatic Diseases: * Alternative therapies * Angiogenesis * Anti-sense oligonucleotides against growth factors * Brachytherapy * Conformal radiotherapy * Cryotherapy * Cyclotron fast neutron treatment * Enhancing the results of radical prostatectomy * Epidemiology of prostate cancer and prostatic diseases * Familial prostate cancer * Free to total PSA * Gene therapy for prostate cancer * Genetic basis for prostate cancer Hormone-related disease * How significant is PSA-detected disease? * Intermittent antiandrogen therapy * Mechanisms of tumour invasion in prostate cancer * Medical and surgical therapies for BPH * Medical therapy for BPH: the road ahead * Natural history of prostate cancer and prostatic diseases * Nutrition in prostate cancer and prostatic diseases * Photodynamic therapy * Prognostic markers * Prostate cancer and potency and impotence * Prostatic intra-epithelial neoplasia - an important precursor of cancer * Prostatitis: quo vadis? * Quality of life issues * Racial issues in prostate cancer * Recurrence after radical prostatectomy * Reproducibility (test-retest reliability) of investigations for prostatic diseases * Reverse transcriptase polymerase chain reaction to detect circulating mRNA for PSA * Role of differentiation therapy * Screening for prostate cancer * Staging of prostate cancer: beyond conventional imaging * The magic bullet - use of PSA promotor gene to target gene therapy * Utility of ultrasensitive PSA assays.

Psycho-Oncologie est une revue scientifique humaniste et multidisciplinaire qui aborde de façon innovante le malade et la maladie dans notre société. Elle a pour objectif de créer des liens entre tous les partenaires de la prise en charge des patients atteints de cancer, mais aussi de leur famille et de leurs soignants. La psycho-oncologie, carrefour entre la médecine et les sciences humaines, discipline unique en son genre, fait l'objet d'une revue qui s'adresse aussi bien aux oncologues, psychologues, psychiatres, infirmières, qu'à tout le personnel de soins. Psycho-oncologie s'intéresse à tous les aspects psychosociaux du cancer et publie des articles originaux, des méta-analyses, des revues de la littérature, des observations cliniques, des comptes rendus, des notes de lectures, des éditoriaux et des articles en anglais, dans les domaines de la médecine, la psychologie et autres sciences humaines (sociologie, anthropologie, économie). Psycho-oncologie est l'organe officiel de la SFPO (SociÃ

Psycho-Oncology is concerned with the psychological, social, behavioral, and ethical aspects of cancer. This subspeciality addresses the two major psychological dimensions of cancer: the psychological responses of patients to cancer at all stages of the disease, and that of their families and caretakers; and the psychological, behavioral and social factors that may influence the disease process. Psycho-oncology is an area of multi-disciplinary interest and has boundaries with the major specialities in oncology: the clinical disciplines (surgery, medicine, pediatrics, radiotherapy), epidemiology, immunology, endocrinology, biology, pathology, bioethics, palliative care, rehabilitation medicine, clinical trials research and decision making, as well as psychiatry and psychology. This international journal is published twelve times a year and will consider contributions to research of clinical and theoretical interest. Topics covered are wide-ranging and relate to the psychosocial aspects of cancer and AIDS-related tumors, including: epidemiology, quality of life, palliative and supportive care, psychiatry, psychology, sociology, social work, nursing and educational issues. Special reviews are offered from time to time. There is a section reviewing recently published books. A society news section is available for the dissemination of information relating to meetings, conferences and other society-related topics. Summary proceedings of important national and international symposia falling within the aims of the journal are presented.

RSC Chemical Biology is a gold open access journal dedicated to publishing and disseminating exceptional, breakthrough research and high-quality reviews at the interface of chemistry and biology. We welcome contributions from across the breadth of the chemical biology field. This includes Sensing and Imaging, Bioorthogonal chemistry, Biosynthesis, Biomimetics and Bioengineering, Synthetic biology, Directed evolution, Drugs development and mechanism of action, Glycoscience, Natural products, Nucleic acids, Peptides, Phenotypic screening, Proteins (including protein-protein interactions, modifications, structure and function) We are particularly interested in reports on the application of chemical tools to probe, explore and visualize biological systems and processes to provide insights into molecular mechanisms in health and disease. We also encourage translational research that bridges chemistry and chemical biology to medicine.

RSC Medicinal Chemistry publishes significant research in medicinal chemistry and related drug discovery science. Research articles published in RSC Medicinal Chemistry must show a breakthrough or significant advance on previously published work, or bring new thinking or results that will have a strong impact in their field. Topics within the journal's scope include, but are not limited to: design, synthesis and biological evaluation of novel chemical entities or biotherapeutic modalities; modifications of known chemical entities or biotherapeutic modalities that result in a significantly greater understanding of their structure-activity relationships, an improvement of their properties or provide other information of significant value; novel methodologies and technologies in the broader chemical and biological sciences; computational, machine learning and artificial intelligence (AI) studies are welcome where they significantly advance medicinal chemistry knowledge; studies that examine the effect of the molecular structure of a compound on pharmacokinetic behaviour and pharmacodynamics; studies that present new insights into drug design based on analysis of existing experimental datasets or new theoretical approaches if supported by experimental evidence; studies presenting new drug delivery systems with novel chemical agents are welcomed, in particular those that involve chemical modification of the delivery system of conjugation with novel delivery vectors.

Radiation Oncology is ready to receive all manuscripts related to the treatment of cancer using radiation.

Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as physical aspects relevant to oncology, particularly in the field of imaging, dosimetry and radiation therapy planning.Papers on more general aspects of interest to the radiation oncologist including chemotherapy, surgery and immunology are also published. Papers are accepted on a worldwide basis.Editorial Office:Radiotherapy and Oncology Secretariat, Professor Jens Overgaard, M.D., Danish Cancer Society, Department of Experimental and Clinical Oncology, Aarhus University Hospital, Building 5, Norrebrogade 44, DK 8000 Aarhus C, DENMARK (Tel: +45 89 49 26 29; Fax: +45 86 19 71 09; email: ro@oncology.dk).